Fresh additions to the Afya Chain catalogue, ready for discovery and procurement.
Formulations: - Parenteral > General injections > IV: 10 mg per mL in ampoule; 1 mg per mL in ampoule; 2 mg per 0.2 mL in ampoule mixed micelle solution; 10 mg per mL in ampoule mixed micelle solution; 1 mg per 0.5 mL in ampoule Oral > Solid > tablet: 5 mg tablet Indications: - Haemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors - Haemorrhagic or haematological disorders of fetus or newborn Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 10 mg per mL in 5 mL ampoule or vial Indications: - Haemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors Source: EML workbook import
Indications: - Other specified atrial fibrillation - Venous thromboembolism Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 100 mg per mL in 10 mL ampoule Indications: - Haemorrhage, not elsewhere classified - Postpartum haemorrhage Source: EML workbook import
Formulations: - Oral > Solid > tablet: 5 mg (scored) (sodium); 1 mg (scored) (sodium); 2 mg (scored) (sodium); 0.5 mg (scored) (sodium); 3 mg (scored) (sodium) Oral > Solid > tablet: 5 mg (scored) (sodium); 1 mg (scored) (sodium); 2 mg (scored) (sodium); 0.5 mg (scored) (sodium); 3 mg (scored) (sodium) Indications: - Other specified diseases of arteries or arterioles - Venous thromboembolism - Cerebral ischaemic stroke due to embolic occlusion - Atrial fibrillation Source: EML workbook import
Formulations: - Oral > Solid > tablet: 40 mg Indications: - Migraine Source: EML workbook import
Formulations: - Oral > Liquid: 125 mg per 5 mL; 120 mg per 5 mL; 250 mg per 5 mL Local > Rectal > Suppository: 250 mg Oral > Solid > dispersible tablet: 100 mg; 250 mg Oral > Solid > tablet: 250 mg; 325 mg; 500 mg - Oral > Liquid: 125 mg per 5 mL; 120 mg per 5 mL; 250 mg per 5 mL Local > Rectal > Suppository: 100 mg; 250 mg Oral > Solid > dispersible tablet: 100 mg; 250 mg Oral > Solid > tablet: 250 mg; 325 mg; 500 mg Indications: - Migraine - Pain Source: EML workbook import
Formulations: - Oral > Solid > tablet: 50 mg - Parenteral > General injections > SC: 6 mg per 0.5 mL in pre-filled pen; 6 mg per 0.5 mL in pre-filled syringe Indications: - Migraine - Trigeminal autonomic cephalalgias Source: EML workbook import
Formulations: - Oral > Solid > tablet: 333 mg Indications: - Disorders due to use of alcohol Source: EML workbook import
Formulations: - Parenteral > General injections > IM: 380 mg in vial (extended-release) Oral > Solid > tablet: 50 mg Indications: - Disorders due to use of alcohol Source: EML workbook import
Formulations: - Oral > Solid: 20 mg (as hydrochloride) Indications: - Generalised anxiety disorder - Panic disorder - Social anxiety disorder - Depressive disorders - Obsessive-compulsive disorder - Palliative care Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.
